U.S. Government Must Increase Global Health R&D Funding To Protect Americans, Stimulate U.S. Economy
The Hill: As global disease threat rises, U.S. funding for research falls
Jamie Bay Nishi, director of the Global Health Technologies Coalition
“…[I]nfectious diseases and other emerging health challenges are a threat everywhere — and not just a problem for low-income countries. The United States and the entire world must be equipped with tools to quickly address emerging threats, small and large. … Yet, U.S. government funding for researching these and other diseases like HIV/AIDS and malaria has reached historic lows. … We cannot wait for an epidemic to trigger R&D — it is simply too late. Real-time, responsive funding cannot make up lost ground. Today’s innovations are the result of yesterday’s R&D investments. By reducing U.S. commitments now, we undermine our ability to respond to future threats. … To uphold President Trump’s promise to keep Americans safe and prosperous, the U.S. government must reassert its leadership in global health innovation, increase research funding, and recommit to advancing the R&D needed to conquer major disease threats of our times. American-led innovation is an antidote to the threat of disease and key to eliminating HIV/AIDS, malaria, tuberculosis, and pandemics that will emerge as Ebola did several years ago. Through strong, sustainable investments in R&D for global diseases, the U.S. government can protect Americans and stimulate the U.S. economy, while delivering a healthier, more prosperous, and stable world” (2/24).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.